The following speakers have received an honorarium from Novo Nordisk for their input to and facilitation of this educational material:

- Prof. Aleksander Krag, University of Southern Denmark, Odense University Hospital, Denmark

- Prof. Geltrude Mingrone, King’s College London, UK, and Università Cattolica del S. Cuore, Italy

1. Kasper P, et al. Clin Res Cardiol. 2021;110:921–937

2. Muzurović E, et al. Hypertension. 2022;79:1319–1326

  • To raise awareness of MASLD/MASH as a manifestation of metabolic disease
  • To improve understanding of risk factors and comorbidities for MASLD/MASH, focusing on type 2 diabetes
  • To highlight the role of endocrinology in the diagnosis and management of people with MASLD/MASH, in light of potential metabolic comorbidities such as obesity and type 2 diabetes
  • To discuss optimal multidisciplinary collaboration between endocrinology, primary care and hepatology to improve care of people with MASLD/MASH

Speakers